LAB R&D to Revenue
Standard Biotools Inc · R&D to Revenue
LAB R&D to Revenue
Latest reported30.45%period ending
LAB FY R&D/Revenue (243.65% → 30.45%)
Latest values, visible window
High-resolution chart · PNG
LAB r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 30.4543% | |
| 35.7796% | |
| 24.401% | |
| 38.1651% | |
| 29.0578% | |
| 26.3935% | |
| 26.9867% | |
| 26.5837% | |
| 30.2402% | |
| 36.7798% | |
| 34.2283% | |
| 37.287% | |
| 27.7173% | |
| 31.7232% | |
| 32.5114% | |
| 38.7574% | |
| 48.4614% | |
| 91.3208% | |
| 197.7869% | |
| 243.6543% |